Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction

Published:2021-04 Issue:15 Volume:77 Page:1859-1870
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cho Kyung Hoon,Han Xiongyi,Ahn Joon Ho,Hyun Dae Young,Kim Min Chul,Sim Doo Sun,Hong Young Joon,Kim Ju Han,Ahn Youngkeun,Hwang Jin Yong,Oh Seok Kyu,Cha Kwang Soo,Choi Cheol Ung,Hwang Kyung-Kuk,Gwon Hyeon Cheol,Jeong Myung Ho

Funder

Chonnam National University

Korea Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction;Schömig;Eur Heart J,2006

2. Characteristics, in-hospital management and outcome of late acute ST-elevation myocardial infarction presenters;Cerrato;J Cardiovasc Med,2017

3. Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality;McNair;Int J Cardiol Heart Vasc,2019

4. Temporal trends in latecomer STEMI patients: insights from the AMIS Plus registry 1997-2017;Roberto;Rev Esp Cardiol,2020

5. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell WGCNA Combined with Transcriptome Sequencing to Study the Molecular Mechanisms of Inflammation-Related Ferroptosis in Myocardial Ischemia-Reperfusion Injury;Journal of Inflammation Research;2024-09

2. Characteristics, management and outcome of patients with late-arrival STEMI in the Acute Coronary Syndrome Israeli Surveys (ACSIS);IJC Heart & Vasculature;2024-08

3. SGLT2 inhibitor Dapagliflozin alleviates cardiac dysfunction and fibrosis after myocardial infarction by activating PXR and promoting angiogenesis;Biomedicine & Pharmacotherapy;2024-08

4. Symptom-to-balloon time and risk of ventricular arrhythmias in patients with STEMI undergoing percutaneous coronary intervention: The VERY-STEMI study;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06

5. Effectiveness of Primary Coronary Intervention for Patients With Delayed ST-Segment Elevation Myocardial Infarction: Insights from Moroccan Cardiology Intensive Care Units;The American Journal of Cardiology;2024-04